Roche Wins FDA Approval to Expand HER2 Diagnostic Testing for Gastroesophageal Cancer

Roche  announced that it has received FDA approval for expanded use of its PATHWAY® HER2 (4B5) and VENTANA® HER2 Dual ISH DNA Probe Coc...

August 28, 2026 | Friday | News
Revolution Medicines Wins FDA Approval for RASONQUE in Metastatic Pancreatic Cancer

Revolution Medicines, Inc., a global commercial-stage oncology company dedicated to discovering, developing and delivering innovative medicines for patie...

August 28, 2026 | Friday | News
Perceptra Expands Thai Medical AI Across Asia With Launch of Inspectra MMG

Perceptra Co., Ltd., a Thai startup developing artificial intelligence technology for medical image analysis, has officially announced its entry into ...

August 27, 2026 | Thursday | News
Eisai and Biogen Launch Weekly Subcutaneous LEQEMBI IQLIK for Early Alzheimer’s in the U.S.

Eisai Co., Ltd. and Biogen Inc., announced that once weekly lecanemab-irmb subcutaneous injection (brand name: LEQEMBI IQLIK®) is now available in th...

August 26, 2026 | Wednesday | News
Japan Grants Orphan Drug Designation to Alkeus’ Gildeuretinol for Stargardt Disease

Alkeus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to preserving the sight of individuals impacted by retinal diseases, announced that t...

August 26, 2026 | Wednesday | News
Ipsen Completes Acquisition of Kartos Therapeutics, Adding Phase III Myelofibrosis Drug Candidate

Ipsen announced it has completed the acquisition of Kartos Therapeutics, a clinical-stage biopharmaceutical company adding late-stage MDM2 inhibitor navt...

August 24, 2026 | Monday | News
Alvotech and Lotus Pharmaceutical Partner to Commercialize Two Biosimilar Candidates in U.S. and Asia

Alvotech , a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced a str...

August 24, 2026 | Monday | News
InnoCare Pharma Advances Mesutoclax into Phase III AML Trial in China

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced to...

August 19, 2026 | Wednesday | News
Lundbeck Receives FDA Fast Track Designation for Narcolepsy Candidate Lu AH69593

Lundbeck announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Lu AH69593, the company's lead oral orexin 2 rece...

July 27, 2026 | Monday | News
Warburg Pincus Set to Acquire Pantherx Rare in Deal Valued at Over US$7 Billion

Private equity firm Warburg Pincus is reportedly close to acquiring Pantherx Rare, a leading US specialty pharmacy focused on rare and orphan diseases, in ...

July 13, 2026 | Monday | News
Mabion and Oddifact Partner to Advance MabionCD20 for Rare Disease Applications

  Mabion S.A., a Polish biotechnology company, has signed a letter of intent (LoI) with French TechDev company Oddifact SAS to evaluate and advance...

June 18, 2026 | Thursday | News
Circular Genomics and Vitazi.ai Partner to Advance Multimodal Early Detection of Alzheimer’s Disease

Analytical Framework Combines AI-Powered Retinal Imaging with Proprietary Circular RNA Biomarkers to Unlock Scalable, Non-Invasive Pathway for Early-Stag...

May 01, 2026 | Friday | News
AIDS Healthcare Foundation Presses Shareholders to Challenge Gilead Sciences Patent Strategy at 2026 AGM with Proposal 6

With Proposal #6, AIDS group urges shareholders to vote to request the company produce a report on the impact of extended patent exclusivities on patie...

April 29, 2026 | Wednesday | News
PacBio and Covaris Unveil Integrated Workflow to Unlock HiFi Sequencing from FFPE Tumor Samples

PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, and Covaris, a PerkinElmer company and leader in sample...

April 17, 2026 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close